These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31562564)

  • 1. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
    Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
    Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent binding behavior of anthraquinone derivative purpurin interacting with tau-derived peptide protofibril.
    Wu X; Zhu L; Wang G; Zhang Q; Qian Z
    Phys Chem Chem Phys; 2023 Oct; 25(39):26787-26796. PubMed ID: 37781899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
    Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid.
    Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D
    FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.
    Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA
    Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro.
    Aillaud I; Kaniyappan S; Chandupatla RR; Ramirez LM; Alkhashrom S; Eichler J; Horn AHC; Zweckstetter M; Mandelkow E; Sticht H; Funke SA
    Alzheimers Res Ther; 2022 Jan; 14(1):15. PubMed ID: 35063014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
    Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
    J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
    KrishnaKumar VG; Paul A; Gazit E; Segal D
    Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells.
    Panda C; Voelz C; Habib P; Mevissen C; Pufe T; Beyer C; Gupta S; Slowik A
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
    Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
    ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
    Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
    ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6.
    Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y
    J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.
    Zhang W; Smith N; Zhou Y; McGee CM; Bartoli M; Fu S; Chen J; Domena JB; Joji A; Burr H; Lv G; Cilingir EK; Bedendo S; Claure ML; Tagliaferro A; Eliezer D; Veliz EA; Zhang F; Wang C; Leblanc RM
    Acta Biomater; 2024 Jul; 183():341-355. PubMed ID: 38849023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.
    Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY
    J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
    Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
    Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of a d-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice.
    Zhang X; Zhang X; Zhong M; Zhao P; Guo C; Li Y; Wang T; Gao H
    ACS Chem Neurosci; 2020 Dec; 11(24):4240-4253. PubMed ID: 33284003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two VQIXXK motifs for tau fibrillization in vitro.
    Li W; Lee VM
    Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirror-Image Phage Display for the Selection of D-Amino Acid Peptide Ligands as Potential Therapeutics.
    Malhis M; Funke SA
    Curr Protoc; 2024 Feb; 4(2):e957. PubMed ID: 38372457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.